Egetis Awarded US Patent for MCT8 Deficiency Composition
05 May 2026 //
ACCESSWIRE
FDA Priority Review to Egetis` Emcitate NDA for MCT8 Deficiency
27 Mar 2026 //
PHARMIWEB
Italy bans 7 APIs from compounding pharmacies after off-label abuse
21 Aug 2015 //
IN-PHARMA TECHNOLOGIST

Market Place
Sourcing Support